Katz MH, Schwarcz SK, Kellogg TA, Klausner JD, Dilley JW, Gibson S, et al. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health 2002; 92(3): 388-94.
Colfax G, Coates TJ, Husnik MJ, Huang Y, Buchbinder S, Koblin B, et al. Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of san francisco men who have sex with men. J Urban Health 2005; 82(1 Suppl 1): i62-i70.
Stall R, Paul JP, Greenwood G, Pollack LM, Bein E, Crosby GM, et al. Alcohol use, drug use and alcohol-related problems among men who have sex with men: The Urban Men's Health Study. Addiction 2001; 96(11): 1589-601.
Woody GE, Donnell D, Seage GR, Metzger D, Marmor M, Koblin BA, et al. Non-injection substance use correlates with risky sex among men having sex with men: Data from HIVNET. Drug Alcohol Depend 1999; 53(3): 197-205.
Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health 2003; 80(1): 137-46.
Tempalski B, Lieb S, Cleland CM, Cooper H, Brady JE, Friedman SR. HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002. J Urban Health 2009; 86(1): 132-54.
Epperson MW, Khan MR, El-Bassel N, Wu E, Gilbert L. A longitudinal study of incarceration and HIV risk among methadone maintained men and their primary female partners. AIDS Behav 2011; 15(2): 347-55.
Miller M, Neaigus A. Networks, resources and risk among women who use drugs. Soc Sci Med 2001; 52(6): 967-78.
Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, et al. Hepatitis C virus seroconversion among young injection drug users: Relationships and risks. J Infect Dis 2002; 186(11): 1558-64.
Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996; 86(5): 655-61.
World Health Organization. Global report: UNAIDS Report on the global AIDS epidemic . Geneva, Switzerland: WHO; 2012.
World Health Organization. Global report: UNAIDS Report on the global aids epidemic 2010. Geneva, Switzerland: WHO; 2010.
Celentano DD, Cohn S, Davis RO, Vlahov D. Self-efficacy estimates for drug use practices predict risk reduction among injection drug users. J Urban Health 2002; 79(2): 245-56.
Cox J, De P, Morissette C, Tremblay C, Stephenson R, Allard R, et al. Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users. Soc Sci Med 2008; 66(2): 211-20.
Sterk CE, Klein H, Elifson KW. Perceived condom use self-efficacy among at-risk women. AIDS Behav 2003; 7(2): 175-82.
Bandura A. Social cognitive theory: An agentic perspective. Annu Rev Psychol 2001; 52: 1-26.
Pulerwitz J, Amaro H, De Jong W, Gortmaker SL, Rudd R. Relationship power, condom use and HIV risk among women in the USA. AIDS Care 2002; 14(6): 789-800.
Fisher JD, Fisher WA. Changing AIDS-risk behavior. Psychol Bull 1992; 111(3): 455-74.
Bandura A. Perceived self-efficacy in the exercise of control over AIDS infection. Eval Program Plann 1990; 13(1): 9-17.
Kadden RM, Litt MD. The role of self-efficacy in the treatment of substance use disorders. Addict Behav 2011; 36(12): 1120-6.
Farmer MA, Meston CM. Predictors of condom use self-efficacy in an ethnically diverse university sample. Arch Sex Behav 2006; 35(3): 313-26.
Baele J, Dusseldorp E, Maes S. Condom use self-efficacy: Effect on intended and actual condom use in adolescents. J Adolesc Health 2001; 28(5): 421-31.
Brafford LJ, Beck KH. Development and validation of a condom self-efficacy scale for college students. J Am Coll Health 1991; 39(5): 219-25.
Fry C, Rumbold G, Lintzeris N. The blood borne virus transmission risk assessment questionnaire (BBVTRAQ): Administration and procedures manual. Melbourne, Australia: Turning Point Alcohol and Drug Centre; 1998.
Fry CL, Lintzeris N. Psychometric properties of the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ). Addiction 2003; 98(2): 171-8.
Gollub EL, French P, Loundou A, Latka M, Rogers C, Stein Z. A randomized trial of hierarchical counseling in a short, clinic-based intervention to reduce the risk of sexually transmitted diseases in women. AIDS 2000; 14(9): 1249-55.
Waldron HB, Kaminer Y. On the learning curve: The emerging evidence supporting cognitive-behavioral therapies for adolescent substance abuse. Addiction 2004; 99 Suppl 2: 93-105.
Dolan KA, Niven H. A review of HIV prevention among young injecting drug users: A guide for researchers. Harm Reduct J 2005; 2(1): 5.
Ruan Y, Liang S, Zhu J, Li X, Pan SW, Liu Q, et al. Evaluation of harm reduction programs on seroincidence of HIV, hepatitis B and C, and syphilis among intravenous drug users in southwest China. Sex Transm Dis 2013; 40(4): 323-8.
Crepaz N, Marshall KJ, Aupont LW, Jacobs ED, Mizuno Y, Kay LS, et al. The efficacy of HIV/STI behavioral interventions for African American females in the United States: A meta-analysis. Am J Public Health 2009; 99(11): 2069-78.